
zzso treatment is generally associated with toxicity to health zzso One of the reasons for this unpleasant association is that zzso agents have been mostly selected on the basis of an zzso established toxicity towards cancer cell lines and rapidly growing zzso in animal models, and not on the basis of a sophisticated intervention in zzso zzso This strategy of drug development unavoidably produces drugs with toxicity towards normal cells and zzso which also have a high cell turnover and share many characteristics with zzso zzso Therefore it is a continuing challenge to design therapy which is both effective and also has high specificity for the biology of cancer and/or is efficiently targeted to zzso zzso This article describes the mechanisms of zzso of standard zzso and zzso and discussed the possibilities of currently available zzso agents to reduce or prevent these zzso These agents should zzso be selective for normal cells versus cancer cells, be effective in reducing or preventing zzso have no negative impact on zzso therapy and have minimal adverse zzso None of the agents described in this article zzso these criteria completely and therefore we cannot recommend these agents for standard use in daily zzso zzso Nevertheless, there are encouraging data concerning the beneficial effects of zzso for zzso zzso and zzso for zzso and zzso zzso These date warrant further zzso 

